BioSpace News Archive

Proprietary Methylation Technology Selected for Continued Development of Multi-Cancer Test

Liberty Trade Inc. recently announced the launch of its newest line of vegan snacks: Crunch Instinct.

Reporter app accelerates achievement and monitoring for third 90 of 90-90-90 HIV targets

Reports 165% Year-over-Year Revenue Growth and Continued Expansion of Reimbursement Pipeline

AVROBIO, Inc. reported financial results for the first quarter ended March 31, 2019 and provided a business update.

Schrödinger announced that the Company will be presenting on its advanced computational platform, which integrates physics-based molecular simulation and machine learning to accelerate drug discovery, at the upcoming conferences in May

Emerging out of Stealth, Livionex Addresses Unmet Medical Needs in Periodontitis, Cataracts and Herpes Simplex Virus

ElevateBio announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and entrepreneurs.

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST® (pomalidomide) for the treatment of patients with human immunodeficiency virus (HIV)-positive Kaposi sarcoma who have previously received systemic chemotherapy, as well as patients with HIV‐negative Kaposi’s sarcoma.

On World Melanoma Day 2019, the Canadian Dermatology Association urges Canadians to adopt sun-safe practices that will better protect them against melanoma and other forms of skin cancer.